Message Font: Serif | Sans-Serif
No. of Recommendations: 0
>So, to sum:

>1) poorly-defined disease

The disease is only poorly defined by incompetent researchers. Informed physicians who know their stuff are the ones who are going to be using and purchasing Amplgien.

>2) a "treatment" that's been around for (almost) ever with no real >clinical record of success

Perhaps it speaks most that Ampligen's main supporters are patients who have been on it and expert doctors who believe that their patients will benefit. (I've met some of them). Delays in approving the drug (which was first used for CFS in the late 80's) have been due to the government's bias towards viewing CFS as a non-real disease. The flip-side of the issue that it's been 20 years and there's still pressure by all the relevant parties (physicians, patients/advocacy, and Hemispherix) to get Ampligen approved. Surely you wouldn't expect that scenario for ineffective drug meant to treat an ill-defined disease.

>3) self-dealing management

This I know less about. I'm still easing into the world of investment, and am eager to learn more about these aspects of business. (As an aside, are there good sources to get the scoop on a business' management, or is just a question of doing the right internet searches?)
Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.